GenScript Biotech CorporationHKEX: 1548

Interim report 2026

· Issued by GenScript Biotech Corporation via HKEXnews

Filed with HKEX · Stock code 1548 · · 94 pages · English

Summary by 6ix AI

The report highlights significant growth in revenue and gross profit, driven by the company's three major business segments: GenScript Life Science Group, ProBio, and Bestzyme. Additionally, the report discusses the company's commitment to ESG initiatives and operational excellence through the GenScript Business System.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

GenScript Biotech Corporation on 6ix

Earlier from GenScript Biotech

Later from GenScript Biotech

All GenScript Biotech news releases